يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"and range of developmental delays)"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3

    المساهمون: Clinical sciences, Growth and Development, Pediatrics

    المصدر: Cancer

    وصف الملف: Print-Electronic

  4. 4
  5. 5
  6. 6
    Academic Journal

    وصف الملف: application/pdf

    Relation: Ehrlich, Peter F.; Chi, Yueh‐yun; Chintagumpala, Murali M.; Hoffer, Fredric A.; Perlman, Elizabeth J.; Kalapurakal, John A.; Tornwall, Brett; Warwick, Anne; Shamberger, Robert C.; Khanna, Geetika; Hamilton, Thomas E.; Gow, Kenneth W.; Paulino, Arnold C.; Gratias, Eric J.; Mullen, Elizabeth A.; Geller, James I.; Grundy, Paul E.; Fernandez, Conrad V.; Dome, Jeffrey S. (2020). "Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children’s Oncology Group." Cancer 126(15): 3516-3525.; https://hdl.handle.net/2027.42/156248; Cancer; Shamberger RC, Haase GM, Argani P, et al. Bilateral Wilms’ tumors with progressive or nonresponsive disease. J Pediatr Surg. 2006; 41: 652 - 657; discussion 652- 657.; Dome JS, Fernandez CV, Mullen EA, et al. Children’s Oncology Group’s 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013; 60: 994 - 1000.; Dome JS, Perlman EJ, Ritchey ML, et al. Renal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 7 th ed. Lippincott Williams and Wilkins; 2015: 753 - 772.; Dome JS, Graf N, Geller JI, et al. Advances in Wilms tumor treatment and biology: progress through international collaboration. J Clin Oncol. 2015; 33: 2999 - 3007.; Dome JS, Perlman EJ, Graf N. Risk stratification for Wilms tumor: current approach and future directions. Am Soc Clin Oncol Educ Book. 2014; 2014: 215 - 223.; Scott RH, Walker L, Olsen OE, et al. Surveillance for Wilms tumour in at- risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006; 91: 995 - 999.; Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol. 1993; 21: 172 - 181.; Coppes MJ, de Kraker J, van Dijken PJ. Bilateral Wilms’ tumor: long- term survival and some epidemiological features. J Clin Oncol. 1989; 7: 310 - 315.; Dome JS, Huff V. Wilms tumor predisposition. GeneReviews. University of Washington, Seattle; 2016.; Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet. 1998; 79: 268 - 273.; Porteus MH, Narkool P, Neuberg D, et al. Characteristics and outcome of children with Beckwith- Wiedemann syndrome and Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2000; 18: 2026 - 2031.; Brioude F, Kalish JM, Mussa A, et al. Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith- Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol. 2018; 14: 229 - 249.; Ehrlich PF, Dome JS, Shamberger RC, et al. Treatment for patients with bilateral, multicentric, or bilaterally- predisposed unilateral Wilms tumor. Children’s Oncology Group; 2006. www.childrensoncologygroup.org; Coppes MJ, Beckwith JB, Ritchey ML, D- Angio GJ, Green DM, Breslow N. Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group. Cancer. 1999; 85: 1616 - 1625.; de Kraker J, Graf N, Pein F; International Society of Paediatric Oncology Renal Tumour Study Group (SIOP- RTSG). Wilms Tumor Protocol 2001. SIOP- RTSG; 2001. Available from: www.siop- rtsg.eu. Accessed January 2020.; Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New Response Evaluation Criteria in Solid Tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45: 228 - 247.; Ehrlich P, Chi YY, Chintagumpala MM, et al. Results of the first prospective multi- institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children’s Oncology Group. Ann Surg. 2017; 266: 470 - 478.; O- Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979; 35: 549 - 546.; Green DM, Grundy PE, Shamberger RC, Ritchey ML, Grundy P, Dome JS. National Wilms Tumor Study Group V protocol. National Wilms Tumor Study Group; 1995. https://memberschildrensoncologygroup.org/Disc/surgery/surgicalHbooks.asp; Grundy PE, Breslow N, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable- histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005; 23: 7312 - 7321.; Davila Fajardo R, Oldenburger E, Rube C, et al. Evaluation of boost irradiation in patients with intermediate- risk stage III Wilms tumour with positive lymph nodes only: results from the SIOP- WT- 2001 Registry. Pediatr Blood Cancer. 2018; 65: e27085.; Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006; 43: 705 - 715.; Breslow NE, Takashima JR, Ritchey ML, Strong LC, Green DM. Renal failure in the Denys- Drash and Wilms’ tumor- aniridia syndromes. Cancer Res. 2000; 60: 4030 - 4032.; Lange J, Peterson SM, Takashima JR, et al. Risk factors for end stage renal disease in non- WT1- syndromic Wilms tumor. J Urol. 2011; 186: 378 - 386.; Breslow N, Collins AJ, Ritchey ML. End stage renal failure in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005; 174: 1972 - 1975.; Scalabre A, Bergeron C, Brioude F, et al. Is nephron sparing surgery justified in Wilms tumor with Beckwith- Wiedemann syndrome or isolated hemihypertrophy? Pediatr Blood Cancer. 2016; 63: 1571 - 1577.; Romao LPR, Pippi Salle JL, Shuman C, et al. Nephron sparing surgery for unilateral Wilms tumor in children with predisposing syndromes: single center experience over 10 years. J Urol. 2012; 188 ( 4 suppl ): 1493 - 1498.; Wu HY, Snyder HM 3rd, D- Angio GJ. Wilms’ tumor management. Curr Opin Urol. 2005; 15: 273 - 276.; Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor- aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2003; 21: 4579 - 4585.; Tournade MF, Com- Nougue C, de Kraker J, et al. Optimal duration of preoperative chemotherapy in unilateral nonmetastatic Wilms tumor in children older than six months. Results of the ninth International Society of Pediatric Oncology tumor trial. J Clin Oncol. 2001; 19: 488 - 500.; McNeil DE, Brown M, Ching A, Debraun MR. Screening for Wilms tumor and hepatoblastoma in children with Beckwith- Wiedemann syndromes: a cost- effective model. Med Pediatr Oncol. 2001; 37: 349 - 356.; Choyke PL, Siegel MJ, Craft AW, Green DM, Debraun MR. Screening for Wilms tumor in children with Beckwith- Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol. 1999; 32: 196 - 200.